Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin

Stock Information for Oramed Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Issues Letter to Shareholders
Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt
Oramed Letter to Shareholders
Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock
Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation
Oramed Letter to Shareholders
Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company
Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.